{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:51:40Z","timestamp":1768452700567,"version":"3.49.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Vital Health Interventions"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0208427","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T22:09:48Z","timestamp":1544134188000},"page":"e0208427","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["E4orf1: A protein for enhancing glucose uptake despite impaired proximal insulin signaling"],"prefix":"10.1371","volume":"13","author":[{"given":"Anuradha A.","family":"Shastri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Peddibhotla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Feizy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-1064","authenticated-orcid":true,"given":"Nikhil V.","family":"Dhurandhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"issue":"2","key":"ref1","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"G Wilcox","year":"2005","journal-title":"Clin Biochem Rev"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"J Boucher","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbadis.2008.10.019","article-title":"Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans","volume":"1792","author":"S Frojdo","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI10842","article-title":"Obesity and insulin resistance","volume":"106","author":"BB Kahn","year":"2000","journal-title":"J Clin Invest"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.1995.75.3.473","article-title":"Pathophysiology of insulin resistance in human disease","volume":"75","author":"GM Reaven","year":"1995","journal-title":"Physiol Rev"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/diab.41.4.476","article-title":"Pioglitazone increases insulin sensitivity by activating insulin receptor kinase","volume":"41","author":"M Kobayashi","year":"1992","journal-title":"Diabetes"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/1043-6618(94)80104-5","article-title":"Re-evaluation of a biguanide, metformin: mechanism of action and tolerability","volume":"30","author":"CR Sirtori","year":"1994","journal-title":"Pharmacol Res"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ijo.2012.6","article-title":"Insulin receptor-independent upregulation of cellular glucose uptake","volume":"37","author":"R Krishnapuram","year":"2013","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"e23394","DOI":"10.1371\/journal.pone.0023394","article-title":"E4orf1: a novel ligand that improves glucose disposal in cell culture","volume":"6","author":"EJ Dhurandhar","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2337\/db07-1311","article-title":"Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36","volume":"57","author":"PM Rogers","year":"2008","journal-title":"Diabetes"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/db07-1313","article-title":"Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling","volume":"57","author":"ZQ Wang","year":"2008","journal-title":"Diabetes"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/oby.2006.222","article-title":"Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats","volume":"14","author":"M Pasarica","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"E779","DOI":"10.1152\/ajpendo.00703.2010","article-title":"Template to improve glycemic control without reducing adiposity or dietary fat","volume":"300","author":"R Krishnapuram","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ijo.2009.196","article-title":"Human obesity relationship with Ad36 adenovirus and insulin resistance","volume":"33","author":"GM Trovato","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1478-3231.2009.02127.x","article-title":"Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease","volume":"30","author":"GM Trovato","year":"2010","journal-title":"Liver Int"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/ijo.2017.142","article-title":"Insulin-sparing and fungible effects of E4orf1 combined with an adipocyte-targeting sequence in mouse models of type 1 and type 2 diabetes","volume":"41","author":"IS Yoon","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2337\/db16-0876","article-title":"Hepatic Expression of Adenovirus 36 E4ORF1 Improves Glycemic Control and Promotes Glucose Metabolism Through AKT Activation","volume":"66","author":"TB McMurphy","year":"2017","journal-title":"Diabetes"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.molmet.2015.07.004","article-title":"E4orf1 induction in adipose tissue promotes insulin-independent signaling in the adipocyte","volume":"4","author":"CM Kusminski","year":"2015","journal-title":"Mol Metab"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biochi.2015.12.002","article-title":"An adenovirus-derived protein: A novel candidate for anti-diabetic drug development","volume":"121","author":"V Hegde","year":"2016","journal-title":"Biochimie"},{"issue":"8","key":"ref20","first-page":"1","article-title":"E4orf1 Enhances Glucose Uptake Independent of Proximal Insulin Signaling","volume":"11","author":"Ha-Na Na","year":"2016","journal-title":"Plos One"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"e23394","DOI":"10.1371\/journal.pone.0023394","article-title":"E4orf1: A Novel Ligand that Improves Glucose Disposal in Cell Culture","volume":"6","author":"EJ Dhurandhar","year":"2011","journal-title":"PLoS ONE"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"e47813","DOI":"10.1371\/journal.pone.0047813","article-title":"E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia","volume":"7","author":"EJ Dhurandhar","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"e0161275","DOI":"10.1371\/journal.pone.0161275","article-title":"E4orf1 Enhances Glucose Uptake Independent of Proximal Insulin Signaling","volume":"11","author":"HN Na","year":"2016","journal-title":"PLoS One"},{"issue":"29","key":"ref24","doi-asserted-by":"crossref","first-page":"19288","DOI":"10.1016\/S0021-9258(18)54996-6","article-title":"Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors","volume":"266","author":"R Schumacher","year":"1991","journal-title":"J Biol Chem"},{"issue":"16","key":"ref25","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1021\/jm9002395","article-title":"Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach","volume":"52","author":"R Li","year":"2009","journal-title":"J Med Chem"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbrc.2010.06.070","article-title":"S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats","volume":"398","author":"A Vikram","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"e60651","DOI":"10.1371\/journal.pone.0060651","article-title":"Doxycycline-regulated 3T3-L1 preadipocyte cell line with inducible, stable expression of adenoviral E4orf1 gene: a cell model to study insulin-independent glucose disposal","volume":"8","author":"R Krishnapuram","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neo.2014.08.006","article-title":"Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress","volume":"16","author":"ME Doscas","year":"2014","journal-title":"Neoplasia"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"e51972","DOI":"10.1371\/journal.pone.0051972","article-title":"Agonism and antagonism at the insulin receptor","volume":"7","author":"L Knudsen","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2337\/db15-0529","article-title":"Glucose Induces Mouse beta-Cell Proliferation via IRS2, MTOR, and Cyclin D2 but Not the Insulin Receptor","volume":"65","author":"RE Stamateris","year":"2016","journal-title":"Diabetes"},{"issue":"19","key":"ref31","doi-asserted-by":"crossref","first-page":"16541","DOI":"10.1074\/jbc.C111.228908","article-title":"Insulin-stimulated GLUT4 protein translocation in adipocytes requires the Rab10 guanine nucleotide exchange factor Dennd4C","volume":"286","author":"H Sano","year":"2011","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"ref32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/BJ20050887","article-title":"AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain","volume":"391","author":"CP Miinea","year":"2005","journal-title":"Biochem J"},{"issue":"8","key":"ref33","first-page":"452","article-title":"New and emerging drugs and targets for type 2 diabetes: reviewing the evidence","volume":"7","author":"BR Miller","year":"2014","journal-title":"Am Health Drug Benefits"},{"issue":"5","key":"ref34","first-page":"303","article-title":"Current therapies and emerging drugs in the pipeline for type 2 diabetes","volume":"4","author":"QT Nguyen","year":"2011","journal-title":"Am Health Drug Benefits"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/rmv.1852","article-title":"Role of adenoviruses in obesity","volume":"25","author":"JD Voss","year":"2015","journal-title":"Rev Med Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S1473-3099(11)70274-2","article-title":"A framework for identification of infections that contribute to human obesity","volume":"11","author":"NV Dhurandhar","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref37","article-title":"Human adenovirus Ad36 and its E4orf1 gene enhance cellular glucose uptake even in presence of inflammatory cytokines","author":"HN Na","year":"2013","journal-title":"Obesity Abstract Book"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jdiacomp.2012.09.006","article-title":"Insulin sparing action of Adenovirus 36 and its E4orf1 protein","volume":"27","author":"NV Dhurandhar","year":"2013","journal-title":"Journal of Diabetes and Its Complications"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1172\/JCI117909","article-title":"Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects","volume":"95","author":"LJ Goodyear","year":"1995","journal-title":"J Clin Invest"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI6928","article-title":"Normal insulin-dependent activation of Akt\/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes","volume":"104","author":"YB Kim","year":"1999","journal-title":"J Clin Invest"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.onc.1206151","article-title":"Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein","volume":"22","author":"KK Frese","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"e1004102","DOI":"10.1371\/journal.ppat.1004102","article-title":"The Human Adenovirus E4-ORF1 Protein Subverts Discs Large 1 to Mediate Membrane Recruitment and Dysregulation of Phosphatidylinositol 3-Kinase","volume":"10","author":"K Kong","year":"2014","journal-title":"PLoS pathogens"},{"key":"ref43","article-title":"Hijacking Discs Large 1 for Oncogenic Phosphatidylinositol 3-Kinase Activation in Human Epithelial Cells Is a Conserved Mechanism of Human Adenovirus E4-ORF1 Proteins","author":"M Kumar","year":"2014","journal-title":"Journal of virology"},{"issue":"suppl 1","key":"ref44","first-page":"S86","article-title":"Ad36 E4orf1: A novel ligand to attenuate hepatic steatosis without weight loss?","volume":"19","author":"EJ Dhurandhar","year":"2011","journal-title":"Obesity"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0208427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T20:19:41Z","timestamp":1662581981000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0208427"}},"subtitle":[],"editor":[{"given":"Makoto","family":"Kanzaki","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0208427","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]}}}